Thu07182019

Robins Global News & Noticias



  • Gaming Chair Review
    Gaming Chair Review
  • Data Recovery Review
    Data Recovery Review
  • Online Video Editors
    Online Video Editors
  • Download TV Series
    Download TV Series
  • All Elite Wrestling
    All Elite Wrestling
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference


LA JOLLA, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Geoffrey O'Brien, JD/MBA, Vice President and Executive Officer, will present a corporate overview at the 20th Annual B. Riley FBR Institutional Investor Conference on Wednesday, May 22, 2019 at 11:30 am at the Beverly Hilton Hotel in Beverly Hills, California.  MediciNova will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through B. Riley FBR.
About MediciNovaMediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market. MediciNova's current strategy is to focus on MN-166 (ibudilast) for neurological disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), degenerative cervical myelopathy (DCM), substance dependence (e.g., alcohol use disorder, methamphetamine dependence, opioid dependence) and glioblastoma (GBM), and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). MediciNova’s pipeline also includes MN‑221 (bedoradrine) and MN-029 (denibulin). For more information on MediciNova, Inc., please visit www.medicinova.com.Statements in this press release that are not historical in nature constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding the future development and efficacy of MN-166, MN-001, MN-221, and MN-029. These forward-looking statements may be preceded by, followed by or otherwise include the words "believes," "expects," "anticipates," "intends," "estimates," "projects," "can," "could," "may," "will," "would," “considering,” “planning” or similar expressions. These forward-looking statements involve a number of risks and uncertainties that may cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause actual results or events to differ materially from t...


Posted: 2019-05-15 23:00:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: MediciNova to Present at the 20th Annual B. Riley FBR Institutional Investor Conference | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

NetworkNewsWire (NNW) Recaps 20th Annual B. Riley FBR Institutional Investor Conference

Fri, 31 May 2019 10:26:00 GMT

NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company, today recaps the recently concluded 20th Annual B. Riley FBR ...

Stoneridge Announces New Presentation Time at the 20th Annual B. Riley FBR Institutional Investor Conference

Wed, 22 May 2019 10:44:00 GMT

NOVI, Mich., May 22, 2019 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) today announced that its previously scheduled presentation has been rescheduled from 1:30 p.m. EDT to 3 p.m. PDT on Thursday, May ...

CytoSorbents to Participate at the B. Riley FBR 20th Annual Institutional Investor Conference

Tue, 21 May 2019 17:00:00 GMT

MONMOUTH JUNCTION, N.J., May 20, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb ® blood purification technology to ...

ZAGG Announces Participation in 20th Annual B. Riley FBR Institutional Investor Conference

Sun, 19 May 2019 17:00:00 GMT

SALT LAKE CITY, May 20, 2019 (GLOBE NEWSWIRE) -- ZAGG Inc (Nasdaq: ZAGG), a leading global mobile lifestyle company, announced today that the Company is participating in the 20 th Annual B. Riley FBR ...

Avid Technology to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

Sun, 19 May 2019 17:00:00 GMT

BURLINGTON, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Avid® (NASDAQ: AVID), the leading technology provider that powers the media and entertainment industry, announced today that Ken Gayron, its ...

Related Twitter Search

  • No items found
  • Related News Story Videos From Youtube

    MY #1 PICK OF 2019✅


    Related Videos On: MY #1 PICK OF 2019✅


    Citi’s 2017 Investor Day: Franchise Overview & Strategy from Michael Corbat, CEO of Citigroup


    Related Videos On: Citi’s 2017 Investor Day: Franchise Overview & Strategy from Michael Corbat, CEO of Citigroup


    Stress Testing: A Discussion and Review (Afternoon)


    Related Videos On: Stress Testing: A Discussion and Review (Afternoon)


    Mark T. Gallogly ’86: Distinguished Leadership in Business Award


    Related Videos On: Mark T. Gallogly ’86: Distinguished Leadership in Business Award


    America's Climate Change Future – Session 3: Institutional dynamics of climate action and inaction


    Related Videos On: America's Climate Change Future – Session 3: Institutional dynamics of climate action and inaction






    Blow Us A Whistle

    Comments (Whistles) Designed By Disqus




    Company Information

    Official Content Providers











    PRIVACY POLICY

    We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
    © 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
    RobinsPost provides links to news sites based on their RSS feeds.
    All trademarks, copyrights, videos, photos and logos are owned by news sources.
    News stories, videos and live streams are from trusted sources:
    Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
    ROBINSPOST Is Proudly Made In America.
    Where Quality, Safety and Service Comes First.